SHIM
TXG icon

Stone House Investment Management’s 10x Genomics TXG Stock Holding History

Stone House Investment Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15K Buy
30
+11
+58% +$288 ﹤0.01% 843
2026
Q1 		$403 Hold
19
– – ﹤0.01% 844
2025
Q4 		$310 Buy
+19
New +$287 ﹤0.01% 754

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Stone House Investment Management's TXG Position: Q2 2026 in Review

Stone House Investment Management increased its 10x Genomics (TXG) stake by 58% in Q2 2026, buying an estimated $288 and bringing the position to 30 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #843.

Stone House Investment Management first reported a position in TXG in Q4 2025 and has held it in 3 quarters since. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Stone House Investment Management held 30 shares of 10x Genomics worth $1.15K as of Q2 2026.
  • Stone House Investment Management bought 11 10x Genomics shares in Q2 2026, an estimated $288.
  • 10x Genomics made up ﹤0.01% of Stone House Investment Management's portfolio in Q2 2026, its #843 holding.
  • Stone House Investment Management first reported a position in 10x Genomics in Q4 2025 and has held it in 3 quarters since.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.